glp 1 prescribing guidelines WHO recognizes GLP-1 medications for long-term obesity treatment Monitoring Report: GLP-1 RA Prescribing

doi: 10.3390/molecules25245789 [DOI] [PMC free article] [PubMed] [Google Scholar] 82

3 That study didnt report why 50% of diabetics on GLP-1 RAs discontinued them, but gastrointestinal (GI) adverse events were a suggested cause

only 43% of participants met the lower end of this g/kg/day recommendation

Drinking alcohol too soon after taking Wegovy may intensify side effects like nausea and vomiting

Open access: link.springer.com/article/10.118 GLP-1 agonists like Ozempic are wonder drugs and are changing medicine and public health as well as our understanding about the link between adiposity-chronic systemic inflammation and chronic pain states